NASDAQ
Cocrystal Pharma, Inc. (COCP) has a current ratio of 3.68x as of Monday, May 25, 2026. This represents a 82.71% decrease compared to its 12-month average of 21.28x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.